D. Gilliland

D. Gilliland

Director/Board Member presso NUVALENT, INC.

Patrimonio netto: 2 M $ in data 31/03/2024

69 anni
Health Technology
Commercial Services
Consumer Services

Profilo

D.
Gary Gilliland
is currently an Independent Director at Laboratory Corp.
of America Holdings and Nuvalent, Inc. He is also a Member of the American Academy of Arts & Sciences, the National Academy of Medicine (United States), the Association of American Physicians, and the American Society of Clinical Investigation.
Previously, he served as the President & Director of the Fred Hutchinson Cancer Research Center from 2015 to 2020.
He was also the Director-Leukemia Program at Dana-Farber from 2002 to 2009 and the Director-Cancer Stem Cell Program at the Harvard Stem Cell Institute in 2009.
Additionally, he held positions as a Senior Vice President at Merck & Co., Inc. from 2009 to 2013 and as a Senior Vice President at Merck Research Laboratories Massachusetts LLC from 2009 to 2013.
He was a Senior Vice President at The University of Pennsylvania Health System and a Senior Vice President at the Trustees of the University of Pennsylvania from 2013 to 2015.
He was a Vice Dean & Professor at the Perelman School of Medicine from 2013 to 2020.
Gilliland's education includes a doctorate from the University of California, Los Angeles, an undergraduate degree from the University of California, Davis, and another doctorate from the University of California, San Francisco.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
20/03/2024 8 712 ( 0.01% ) 2 M $ 31/03/2024
15/06/2023 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di D. Gilliland

SocietàPosizioneInizio
LABORATORY CORPORATION OF AMERICA HOLDINGS Director/Board Member 01/04/2014
NUVALENT, INC. Director/Board Member 01/01/2021
Corporate Officer/Principal -
Corporate Officer/Principal -
American Society of Clinical Investigation Corporate Officer/Principal -
Corporate Officer/Principal -
Tutte le posizioni attive di D. Gilliland

Precedenti posizioni note di D. Gilliland

SocietàPosizioneFine
President 01/02/2020
Perelman School of Medicine Corporate Officer/Principal 01/01/2020
Corporate Officer/Principal 01/01/2015
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di D. Gilliland

Formazione di D. Gilliland

University of California, Los Angeles Doctorate Degree
University of California, Davis Undergraduate Degree
The University of California, San Francisco Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di D. Gilliland

Relazioni

100 +

Relazioni di 1° grado

20

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
LABORATORY CORPORATION OF AMERICA HOLDINGS

Health Services

MERCK & CO., INC.

Health Technology

NUVALENT, INC.

Health Technology

Aziende private12

Commercial Services

Miscellaneous

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Services

American Society of Clinical Investigation

Health Technology

Miscellaneous

Health Technology

Commercial Services

Vedi le connessioni aziendali